142 related articles for article (PubMed ID: 22949094)
1. Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2012 Nov; 21(11):1173-82. PubMed ID: 22949094
[TBL] [Abstract][Full Text] [Related]
2. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study.
Myles PR; Hubbard RB; McKeever TM; Pogson Z; Smith CJ; Gibson JE
Pharmacoepidemiol Drug Saf; 2009 Apr; 18(4):269-75. PubMed ID: 19235776
[TBL] [Abstract][Full Text] [Related]
3. Use of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Jackson LA
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):792-802. PubMed ID: 20623507
[TBL] [Abstract][Full Text] [Related]
4. Sources of heterogeneity in case-control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia.
de Groot MC; Klungel OH; Leufkens HG; van Dijk L; Grobbee DE; van de Garde EM
Eur J Epidemiol; 2014 Oct; 29(10):767-75. PubMed ID: 25154551
[TBL] [Abstract][Full Text] [Related]
5. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study.
Dublin S; Walker RL; Jackson ML; Nelson JC; Weiss NS; Von Korff M; Jackson LA
J Am Geriatr Soc; 2011 Oct; 59(10):1899-907. PubMed ID: 22091503
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitor use and pneumonia risk in a general population.
van de Garde EM; Souverein PC; van den Bosch JM; Deneer VH; Leufkens HG
Eur Respir J; 2006 Jun; 27(6):1217-22. PubMed ID: 16455828
[TBL] [Abstract][Full Text] [Related]
7. Do angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers decrease the risk of hospitalization secondary to community-acquired pneumonia? A nested case-control study.
Etminan M; Zhang B; Fitzgerald M; Brophy JM
Pharmacotherapy; 2006 Apr; 26(4):479-82. PubMed ID: 16553505
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes.
van de Garde EM; Souverein PC; Hak E; Deneer VH; van den Bosch JM; Leufkens HG
J Hypertens; 2007 Jan; 25(1):235-9. PubMed ID: 17143196
[TBL] [Abstract][Full Text] [Related]
9. Anticholinergic medications and risk of community-acquired pneumonia in elderly adults: a population-based case-control study.
Paul KJ; Walker RL; Dublin S
J Am Geriatr Soc; 2015 Mar; 63(3):476-85. PubMed ID: 25726764
[TBL] [Abstract][Full Text] [Related]
10. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors.
Cressman AM; Macdonald EM; Fernandes KA; Gomes T; Paterson JM; Mamdani MM; Juurlink DN;
Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448
[TBL] [Abstract][Full Text] [Related]
11. Statin use and risk of community acquired pneumonia in older people: population based case-control study.
Dublin S; Jackson ML; Nelson JC; Weiss NS; Larson EB; Jackson LA
BMJ; 2009 Jun; 338():b2137. PubMed ID: 19531550
[TBL] [Abstract][Full Text] [Related]
12. The impact of prior outpatient ACE inhibitor use on 30-day mortality for patients hospitalized with community-acquired pneumonia.
Mortensen EM; Restrepo MI; Anzueto A; Pugh J
BMC Pulm Med; 2005 Sep; 5():12. PubMed ID: 16159398
[TBL] [Abstract][Full Text] [Related]
13. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
15. Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.
Majumdar SR; McAlister FA; Cree M; Chang WC; Packer M; Armstrong PW;
Clin Ther; 2004 May; 26(5):694-703. PubMed ID: 15220013
[TBL] [Abstract][Full Text] [Related]
16. Does Angiotensin-Converting Enzyme Inhibitor and β-Blocker Use Reduce the Risk of Primary Liver Cancer? A Case-Control Study Using the U.K. Clinical Practice Research Datalink.
Hagberg KW; Sahasrabuddhe VV; McGlynn KA; Jick SS
Pharmacotherapy; 2016 Feb; 36(2):187-95. PubMed ID: 26846893
[TBL] [Abstract][Full Text] [Related]
17. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study.
Jackson ML; Nelson JC; Weiss NS; Neuzil KM; Barlow W; Jackson LA
Lancet; 2008 Aug; 372(9636):398-405. PubMed ID: 18675690
[TBL] [Abstract][Full Text] [Related]
18. Reduction of risk of pneumonia associated with use of angiotensin I converting enzyme inhibitors in elderly inpatients.
Okaishi K; Morimoto S; Fukuo K; Niinobu T; Hata S; Onishi T; Ogihara T
Am J Hypertens; 1999 Aug; 12(8 Pt 1):778-83. PubMed ID: 10480470
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for developing acute kidney injury in older people with diabetes and community-acquired pneumonia: a population-based UK cohort study.
Jain A; McDonald HI; Nitsch D; Tomlinson L; Thomas SL
BMC Nephrol; 2017 May; 18(1):142. PubMed ID: 28460637
[TBL] [Abstract][Full Text] [Related]
20. Why do covariates defined by International Classification of Diseases codes fail to remove confounding in pharmacoepidemiologic studies among seniors?
Jackson ML; Nelson JC; Jackson LA
Pharmacoepidemiol Drug Saf; 2011 Aug; 20(8):858-65. PubMed ID: 21671442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
